Transcriptome Reveals 1400-Fold Upregulation of APOA4-APOC3 and 1100-Fold Downregulation of GIF in the Patients with Polycythemia-Induced Gastric Injury.
High-altitude polycythemia (HAPC) inducing gastric mucosal lesion (GML) is still out of control and molecular mechanisms remain widely unknown. To address the issues, endoscopy and histopathological analyses were performed. Meanwhile, microarray-based transcriptome profiling was conducted in the gastric mucosa from 3 pairs of healthy subjects and HAPC-induced GML patients. HAPC caused morphological changes and pathological damages of the gastric mucosa of GML patients. A total of 10304 differentially expressed genes (DEGs) were identified, including 4941 up-regulated and 5363 down-regulated DEGs in gastric mucosa of GML patients compared with healthy controls (fold change ≥2, P<0.01 and FDR <0.01). Particularly, apolipoprotein genes APOA4 and APOC3 were 1473-fold and 1468-fold up-regulated in GML patients compared with the controls. In contrast, gastric intrinsic factor (GIF) was 1102-fold down-regulated in GML patients compared with the controls. APOA4 (chr11:116691770-116691711), APOC3 (chr11:116703530-116703589) and GIF (chr11:59603362-59603303) genes are all located on chromosome 11. APOA4 and APOC3 act as an inhibitor of gastric acid secretion while gastric acid promotes ulceration. GIF deficiency activates a program of acute anemia, which may antagonize polycythemia while polycythemia raises the risk of GML. Therefore, the present findings reveal that HAPC-induced GML inspires the protection responses by up-regulating APOA4 and APOC3, and down-regulating GIF. These results may offer the basic information for the treatment of HAPC-induced gastric lesion in the future.
High altitude Medical Research Institute, People's Hospital of Tibet Autonomous Region, Lhasa, 850000, China; Department of Gastroenterology, People's Hospital of Tibet Autonomous Region, Lhasa, 850000, China.
Kang
K
Li
High altitude Medical Research Institute, People's Hospital of Tibet Autonomous Region, Lhasa, 850000, China; Department of Cardiology, People's Hospital of Tibet Autonomous Region, Lhasa, 850000, China.
Luobu
L
Gesang
Department of Gastroenterology, People's Hospital of Tibet Autonomous Region, Lhasa, 850000, China.
Zeng
Z
Dan
Department of Cardiology, People's Hospital of Tibet Autonomous Region, Lhasa, 850000, China.
Lamu
L
Gusang
Department of Cardiology, People's Hospital of Tibet Autonomous Region, Lhasa, 850000, China.
Ciren
C
Dawa
Department of Gastroenterology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, 510180, China.
Yuqiang
Y
Nie
D000328:Adult; D000532:Altitude Sickness / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D053305:Apolipoprotein C-III / Q000235:genetics / Q000378:metabolism*; D001054:Apolipoproteins A / Q000235:genetics / Q000378:metabolism*; D015536:Down-Regulation; D005753:Gastric Mucosa / Q000378:metabolism / Q000473:pathology; D020869:Gene Expression Profiling; D006239:Haplotypes; D006801:Humans; D007437:Intrinsic Factor / Q000235:genetics / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D011086:Polycythemia / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D059467:Transcriptome; D015854:Up-Regulation
D053305:Apolipoprotein C-III; D001054:Apolipoproteins A; C022205:apolipoprotein A-IV; D007437:Intrinsic Factor